These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 837141)

  • 1. Monitoring adverse reactions to drugs.
    Br Med J; 1977 Feb; 1(6058):439. PubMed ID: 837141
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulating reporting of adverse drug reactions by using a fee.
    Feely J; Moriarty S; O'Connor P
    BMJ; 1990 Jan; 300(6716):22-3. PubMed ID: 2105117
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Measurement of side effects of drugs.
    Br Med J; 1974 Jul; 3(5925):258-9. PubMed ID: 4843703
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring adverse reactions to drugs.
    Pearson R
    Br Med J; 1977 Apr; 1(6069):1159. PubMed ID: 861519
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA reforms hampered by budget freeze.
    Jaffe S
    Lancet; 2012 Oct; 380(9852):1458-9. PubMed ID: 23115783
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring adverse reactions to drugs.
    Dollery CT; Rawlins MD
    Br Med J; 1977 Jan; 1(6053):96-7. PubMed ID: 832028
    [No Abstract]   [Full Text] [Related]  

  • 7. The FDA Safety and Innovation Act.
    Steinbrook R; Sharfstein JM
    JAMA; 2012 Oct; 308(14):1437-8. PubMed ID: 23047356
    [No Abstract]   [Full Text] [Related]  

  • 8. A prescription for monitoring drugs.
    Marshall E
    Science; 1980 Feb; 207(4433):853-5. PubMed ID: 7355265
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure and function of a clinical pharmacology consulting service.
    Spector R; Heller A; Johnson MW
    J Clin Pharmacol; 1979; 19(5-6):257-60. PubMed ID: 469021
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reactions without drugs.
    Reidenberg MM
    Lancet; 1967 Oct; 2(7521):892. PubMed ID: 12389559
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?
    Venning GR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):199-202. PubMed ID: 6401528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porton defends nerve-gas tests on humans.
    Mason I
    New Sci; 1987 Jul; 115(1569):30. PubMed ID: 11655830
    [No Abstract]   [Full Text] [Related]  

  • 13. To screen new drugs for safety, Lilly pays homeless alcoholics: it's 'quick cash' to habitues of Indianapolis shelters; it vanishes quickly, too.
    Cohen LP
    Wall St J (East Ed); 1996 Nov; ():A1, A10. PubMed ID: 11648034
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods of monitoring adverse reactions to drugs.
    Venulet J
    Prog Drug Res; 1977; 21():231-92. PubMed ID: 339270
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic signalling of adverse reactions to drugs.
    Finney DJ
    Methods Inf Med; 1974 Jan; 13(1):1-10. PubMed ID: 4826353
    [No Abstract]   [Full Text] [Related]  

  • 16. ADVERSE DRUG REACTIONS AND THE AUSTRALIAN DRUG EVALUATION COMMITTEE.
    GAULT JE
    Med J Aust; 1964 Jul; 2():153-4. PubMed ID: 14176467
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.
    Inman WH
    Br Med J (Clin Res Ed); 1981 Apr; 282(6270):1131-2. PubMed ID: 6786470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk we bear: the effects of review speed and industry user fees on new drug safety.
    Olson MK
    J Health Econ; 2008 Mar; 27(2):175-200. PubMed ID: 18207263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.
    Martin RM; Biswas PN; Freemantle SN; Pearce GL; Mann RD
    Br J Clin Pharmacol; 1998 Nov; 46(5):505-11. PubMed ID: 9833605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for drug monitoring.
    Br Med J; 1977 Apr; 1(6065):861-2. PubMed ID: 851762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.